SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice
© 2024. The Author(s)..
The persistence of SARS-CoV-2 despite the development of vaccines and a degree of herd immunity is partly due to viral evolution reducing vaccine and treatment efficacy. Serial infections of wild-type (WT) SARS-CoV-2 in Balb/c mice yield mouse-adapted strains with greater infectivity and mortality. We investigate if passaging unmodified B.1.351 (Beta) and B.1.617.2 (Delta) 20 times in K18-ACE2 mice, expressing the human ACE2 receptor, in a BSL-3 laboratory without selective pressures, drives human health-relevant evolution and if evolution is lineage-dependent. Late-passage virus causes more severe disease, at organism and lung tissue scales, with late-passage Delta demonstrating antibody resistance and interferon suppression. This resistance co-occurs with a de novo spike S371F mutation, linked with both traits. S371F, an Omicron-characteristic mutation, is co-inherited at times with spike E1182G per Nanopore sequencing, existing in different within-sample viral variants at others. Both S371F and E1182G are linked to mammalian GOLGA7 and ZDHHC5 interactions, which mediate viral-cell entry and antiviral response. This study demonstrates SARS-CoV-2's tendency to evolve with phenotypic consequences, its evolution varying by lineage, and suggests non-dominant quasi-species contribution.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
Communications biology - 7(2024), 1 vom: 16. Feb., Seite 191 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Willett, Julian Daniel Sunday [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.02.2024 Date Revised 19.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s42003-024-05878-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368559971 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368559971 | ||
003 | DE-627 | ||
005 | 20240220232309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240217s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s42003-024-05878-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1300.xml |
035 | |a (DE-627)NLM368559971 | ||
035 | |a (NLM)38365933 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Willett, Julian Daniel Sunday |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.02.2024 | ||
500 | |a Date Revised 19.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a The persistence of SARS-CoV-2 despite the development of vaccines and a degree of herd immunity is partly due to viral evolution reducing vaccine and treatment efficacy. Serial infections of wild-type (WT) SARS-CoV-2 in Balb/c mice yield mouse-adapted strains with greater infectivity and mortality. We investigate if passaging unmodified B.1.351 (Beta) and B.1.617.2 (Delta) 20 times in K18-ACE2 mice, expressing the human ACE2 receptor, in a BSL-3 laboratory without selective pressures, drives human health-relevant evolution and if evolution is lineage-dependent. Late-passage virus causes more severe disease, at organism and lung tissue scales, with late-passage Delta demonstrating antibody resistance and interferon suppression. This resistance co-occurs with a de novo spike S371F mutation, linked with both traits. S371F, an Omicron-characteristic mutation, is co-inherited at times with spike E1182G per Nanopore sequencing, existing in different within-sample viral variants at others. Both S371F and E1182G are linked to mammalian GOLGA7 and ZDHHC5 interactions, which mediate viral-cell entry and antiviral response. This study demonstrates SARS-CoV-2's tendency to evolve with phenotypic consequences, its evolution varying by lineage, and suggests non-dominant quasi-species contribution | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
700 | 1 | |a Gravel, Annie |e verfasserin |4 aut | |
700 | 1 | |a Dubuc, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Gudimard, Leslie |e verfasserin |4 aut | |
700 | 1 | |a Dos Santos Pereira Andrade, Ana Claudia |e verfasserin |4 aut | |
700 | 1 | |a Lacasse, Émile |e verfasserin |4 aut | |
700 | 1 | |a Fortin, Paul |e verfasserin |4 aut | |
700 | 1 | |a Liu, Ju-Ling |e verfasserin |4 aut | |
700 | 1 | |a Cervantes, Jose Avila |e verfasserin |4 aut | |
700 | 1 | |a Galvez, Jose Hector |e verfasserin |4 aut | |
700 | 1 | |a Djambazian, Haig Hugo Vrej |e verfasserin |4 aut | |
700 | 1 | |a Zwaig, Melissa |e verfasserin |4 aut | |
700 | 1 | |a Roy, Anne-Marie |e verfasserin |4 aut | |
700 | 1 | |a Lee, Sally |e verfasserin |4 aut | |
700 | 1 | |a Chen, Shu-Huang |e verfasserin |4 aut | |
700 | 1 | |a Ragoussis, Jiannis |e verfasserin |4 aut | |
700 | 1 | |a Flamand, Louis |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Communications biology |d 2018 |g 7(2024), 1 vom: 16. Feb., Seite 191 |w (DE-627)NLM284287245 |x 2399-3642 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2024 |g number:1 |g day:16 |g month:02 |g pages:191 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s42003-024-05878-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2024 |e 1 |b 16 |c 02 |h 191 |